Assignee
QED THERAPEUTICS INC
US·1 granted patent·3 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
4 records- 0152US2025101002A1Deuterated infigratinib compoundsQED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0247US2024009193A1Methods of treating achondroplasiaQED THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0338US2022233537A1Methods of treating urinary system cancersQED THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0437US12357632B2Methods of treating cholangiocarcinomaQED THERAPEUTICS INC·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when QED THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →